606
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

Active Breathing Coordinator reduces radiation dose to the stomach in patients with left breast cancer

ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Pages 1873-1879 | Received 05 Jul 2023, Accepted 22 Oct 2023, Published online: 01 Nov 2023

References

  • Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–2106. doi:10.1016/S0140-6736(05)67887-7.
  • Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18(6):1220–1229. doi:10.1200/JCO.2000.18.6.1220.
  • Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557–565. doi:10.1016/S1470-2045(05)70251-5.
  • Zureick AH, Grzywacz VP, Almahariq MF, et al. Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2022;114(1):130–139. doi:10.1016/j.ijrobp.2022.04.019.
  • Yang D, Piao Y, Yuan F, et al. Gastric side effects and the stomach dosimetric analysis in left-sided breast cancer radiotherapy in free-breathing and deep inspiration breath-hold technique. Radiat Oncol. 2022;17(1):2. doi:10.1186/s13014-021-01963-7.
  • Maranzano E, De Angelis V, Pergolizzi S, et al. Italian group for antiemetic research in radiotherapy (IGARR). a prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 italian radiation oncology centres. Radiother Oncol. 2010;94(1):36–41. doi:10.1016/j.radonc.2009.11.001.
  • Maranzano E, Latini P, Roila F, et al. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian group for antiemetic research in radiotherapy. Int J Radiat Oncol. 1999;44(3):619–625. doi:10.1016/s0360-3016(99)00055-3.
  • Feyer CP, Maranzano E, Molassiotis A, et al. Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Support Care Cancer. 2005;13(2):122–128. doi:10.1007/s00520-004-0705-3.
  • Santos AM, Marcu LG, Wong CM, et al. Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol. 2016;55(11):1331–1337. doi:10.1080/0284186X.2016.1185150.
  • Iwasa Z, Jinnai D, Koyama H, et al. Second primary cancer following adjuvant chemotherapy, radiotherapy and endocrine therapy for breast cancer: a nationwide survey on 47,005 japanese patients who underwent mastectomy from 1963-1982. Jpn J Surg. 1986;16(4):262–271. doi:10.1007/BF02470935.
  • Lu Y, Yang D, Zhang X, et al. Comparison of deep inspiration breath hold versus free breathing in radiotherapy for left sided breast cancer. Front Oncol. 2022;12:845037. doi:10.3389/fonc.2022.845037.
  • Lai J, Hu S, Luo Y, et al. Meta-analysis of deep inspiration breath hold (DIBH) versus free breathing (FB) in postoperative radiotherapy for left-side breast cancer. Breast Cancer. 2020;27(2):299–307. doi:10.1007/s12282-019-01023-9.
  • Quirk S, Grendarova P, Phan T, et al. A retrospective analysis to demonstrate achievable dosimetry for the left anterior descending artery in left-sided breast cancer patients treated with radiotherapy. Radiother Oncol. 2020;148:167–173. doi:10.1016/j.radonc.2020.04.022.
  • Bartlett FR, Colgan RM, Carr K, et al. The UK HeartSpare study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy. Radiother Oncol. 2013;108(2):242–247. doi:10.1016/j.radonc.2013.04.021.
  • Jabbour SK, Hashem SA, Bosch W, et al. Upper abdominal normal organ contouring guidelines and atlas: a radiation therapy oncology group consensus. Pract Radiat Oncol. 2014;4(2):82–89. doi:10.1016/j.prro.2013.06.004.
  • Clayman C, Palmer W, Kirsner J. Gastric irradiation in the treatment of peptic ulcer. Gastroenterology. 1968;55(3):403–407. doi:10.1016/s0016-5085(19)34051-x.
  • Lazzari G, Terlizzi A, Leo MG, et al. VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: the incidental effect of low-dose bath exposure. Clin Transl Radiat Oncol. 2017;7:43–48. doi:10.1016/j.ctro.2017.09.009.
  • Cho WK, Choi DH, Park W, et al. Gastric complications after adjuvant radiotherapy for breast cancer. J Breast Cancer. 2019;22(3):464–471. doi:10.4048/jbc.2019.22.e42.
  • Andersson M, Jensen MB, Engholm G, et al. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in danish breast cancer cooperative group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. Acta Oncol. 2008;47(4):755–764. doi:10.1080/02841860801978921.
  • Marcu LG, Santos A, Bezak E. Risk of second primary cancer after breast cancer treatment. Eur J Cancer Care (Engl). 2014;23(1):51–64. doi:10.1111/ecc.12109.
  • Mellemkjaer L, Friis S, Olsen JH, et al. Risk of second cancer among women with breast cancer. Int J Cancer. 2006;118(9):2285–2292. doi:10.1002/ijc.21651.
  • Das P, Abboud MT, Haque W, et al. Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma. Pract Radiat Oncol. 2013;3(4):344–348. doi:10.1016/j.prro.2012.11.001.
  • Liu Q, Cai XW, Fu XL, et al. Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma. Oncotarget. 2015;6(31):32220–32227. doi:10.18632/oncotarget.4730.
  • Yoon H, Oh D, Park HC, et al. Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma. Strahlenther Onkol. 2013;189(7):541–546. doi:10.1007/s00066-013-0343-0.
  • Umezawa R, Nakagawa K, Mizuma M, et al. Comparison of acute gastrointestinal toxicities between 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy including prophylactic regions in chemoradiotherapy with S-1 for pancreatic cancer-importance of dose volume histogram parameters in the stomach as the predictive factors. J Radiat Res. 2022;63(6):856–865. doi:10.1093/jrr/rrac049.
  • Nakamura A, Shibuya K, Matsuo Y, et al. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;84(2):369–375. doi:10.1016/j.ijrobp.2011.12.026.
  • Holyoake DLP, Warren DR, Hurt C, et al. Stomach Dose-Volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer. Clin Oncol (R Coll Radiol). 2018;30(7):418–426. doi:10.1016/j.clon.2018.02.067.
  • Feng M, Normolle D, Pan CC, et al. Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys. 2012;84(1):e1–e6. doi:10.1016/j.ijrobp.2012.02.029.
  • van den Belt-Dusebout AW, Aleman BM, Besseling G, et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys. 2009;75(5):1420–1429. doi:10.1016/j.ijrobp.2009.01.073.
  • Ozasa K, Shimizu Y, Suyama A, et al. Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 2012;177(3):229–243. doi:10.1667/rr2629.1.
  • Chon YE, Seong J, Kim BK, et al. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys. 2011;81(5):1343–1351. doi:10.1016/j.ijrobp.2010.07.1986.
  • Fraser AG, Pounder RE, Burroughs AK. Gastric secretion and peptic ulceration in cirrhosis. J Hepatol. 1993;19(1):171–182. doi:10.1016/s0168-8278(05)80191-6.
  • Siavashpour Z, Moghani MM, Goharpey N, et al. Correlation between gastric volume and organs at risk dose in adjuvant radiotherapy for left breast cancer. Rep Pract Oncol Radiother. 2021;26(3):367–379. doi:10.5603/RPOR.a2021.0067.
  • Szarka LA, Camilleri M, Vella A, et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008;6(6):635–643.e1. doi:10.1016/j.cgh.2008.01.009.
  • Tougas G, Chen Y, Coates G, et al. Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol. 2000;95(1):78–86. doi:10.1111/j.1572-0241.2000.01703.x.
  • Mankinen M, Virén T, Seppälä J, et al. Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation. Radiat Oncol. 2022;17(1):46. doi:10.1186/s13014-022-02014-5.
  • Cilla S, Romano C, Craus M, et al. Reproducibility and stability of spirometer-guided deep inspiration breath-hold in left-breast treatments using an optical surface monitoring system. J Appl Clin Med Phys. 2023;24(6):e13922. doi:10.1002/acm2.13922.
  • Peters GW, Gao SJ, Knowlton C, et al. Benefit of deep inspiratory breath hold for right breast cancer when regional lymph nodes are irradiated. Pract Radiat Oncol. 2022;12(1):e7–e12. doi:10.1016/j.prro.2021.08.010.
  • Pandeli C, Smyth LML, David S, et al. Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study. Radiat Oncol. 2019;14(1):223. doi:10.1186/s13014-019-1430-x.